Abellanosa, Gabriel .
HRN: 25-61-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/06/2024
08/12/2024
IV
75mg
Q8h
Age With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes